Ro KhannaBuy
HRTX Common Stock · Transaction Jun 2, 2022 · Filed Jun 10, 2022 · Amount pending receipt enrichment
XNAS · HRTX
+3.94% · +$0.0126 · Vol Not reported
Pre-market · updated 04:00:16 ET
Heron Therapeutics, Inc.
PHARMACEUTICAL PREPARATIONS
$0.3326
Veridion Score
BETAMEDIUM CONF · 5/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · HRTX
MethodologySentiment absence reason unknown
HRTX
Heron Therapeutics, Inc.
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
46/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is HRTX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Heron Therapeutics, Inc.
PHARMACEUTICAL PREPARATIONSListed since
1987
Employees
128
Country
US
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$0.3200
Last session
Day high
$0.3200
Last session
Day low
$0.3200
Last session
Previous close
$0.3200
52W high
$1.49
-77.68% from high
52W low
$0.3200
1% of range
Market cap
$63.9M
Beta
1.65
Shares out
189.9M
Avg volume
2.9M
VWAP
$0.3200
Last session
Price history computed in-house
1W
+2.72%
1M
-29.34%
3M
-60.64%
1Y
-74.42%
YTD
-74.42%
SMA 50 $0.4320 · below
SMA 200 $0.9415 · below
52W position 1%
HRTX overview
Related filings and maps
Public disclosures
Congress activity in HRTX
Official filing ↗
Ro KhannaBuy
HRTX Common Stock · Transaction Sep 28, 2021 · Filed Oct 14, 2021 · Amount pending receipt enrichment
Heron Therapeutics, Inc. · Transaction Mar 31, 2021 · Filed Apr 5, 2021 · $1,001 to $15,000
Federal contracts
HRTX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HRTX in this window.
Lobbying spend
HRTX lobbying filings, year to date.
Registered lobbying filings matched to Heron Therapeutics, Inc..
$150.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Medicare/Medicaid
Filing
$50.0K
HERON THERAPEUTICS INC.
FARRAGUT PARTNERS LLP
Jul 20, 2026
Filing
$50.0K
HERON THERAPEUTICS INC.
FARRAGUT PARTNERS LLP
Apr 20, 2026
Filing
$50.0K
HERON THERAPEUTICS INC.
FARRAGUT PARTNERS LLP
Jan 20, 2026
Analyst ratings
Sovereign unlock shows live analyst consensus for HRTX.
Options
Sovereign unlock shows live options positioning for HRTX.